Location: Jean Mayer Human Nutrition Research Center On Aging
Title: Genetic biomarkers of metabolic detoxification for personalized lifestyle medicineAuthor
ARONICA, LUCIA - Metagenics, Inc | |
ORDOVAS, JOSE - Jean Mayer Human Nutrition Research Center On Aging At Tufts University | |
VOLKOV, ANDREY - Bennet Data Sciences | |
LAMB, JOSEPH - Personalized Lifestyle Medicine Center | |
STONE, PETER MICHAEL - Personalized Lifestyle Medicine Center | |
MINICH, DEANNA - Institute For Functional Medicine Federal Way | |
LEARY, MICHELLE - Vida Integrated Health | |
CLASS, MONIQUE - Institute For Functional Medicine Federal Way | |
METTI, DINA - Personalized Lifestyle Medicine Center | |
LARSON, ILONA - Metagenics, Inc | |
CONTRACTOR, NIKHAT - Nutrilite Health Institute | |
ECK, BRENT - Metagenics, Inc | |
BLAND, JEFFREY - Personalized Lifestyle Medicine Center |
Submitted to: Nutrients
Publication Type: Review Article Publication Acceptance Date: 2/8/2022 Publication Date: 2/11/2022 Citation: Aronica, L., Ordovas, J.M., Volkov, A., Lamb, J.J., Stone, P., Minich, D.M., Leary, M., Class, M., Metti, D., Larson, I.A., Contractor, N., Eck, B., Bland, J. 2022. Genetic biomarkers of metabolic detoxification for personalized lifestyle medicine. Nutrients. https://doi.org/10.3390/nu14040768. DOI: https://doi.org/10.3390/nu14040768 Interpretive Summary: Technical Abstract: Metabolic detoxification (detox)-or biotransformation-is a physiological function that removes toxic substances from our body. Genetic variability and dietary factors may affect the function of detox enzymes, thus impacting the body's sensitivity to toxic substances of endogenous and exogenous origin. From a genetic perspective, most of the current knowledge relies on observational studies in humans or experimental models in vivo and in vitro, with very limited proof of causality and clinical value. This review provides health practitioners with a list of single nucleotide polymorphisms (SNPs) located within genes involved in Phase I and Phase II detoxification reactions, for which evidence of clinical utility does exist. We have selected these SNPs based on their association with interindividual variability of detox metabolism in response to certain nutrients in the context of human clinical trials. In order to facilitate clinical interpretation and usage of these SNPs, we provide, for each of them, a strength of evidence score based on recent guidelines for genotype-based dietary advice. We also present the association of these SNPs with functional biomarkers of detox metabolism in a pragmatic clinical trial, the LIFEHOUSE study. |